Brief: Spago Nanomedical Q1 Sales SEK 350 Thousand
May 02 (Reuters) - Spago Nanomedical Q1 net income SEK -7.763 thousand. * Q1 adjusted EPS SEK -0.03 * Q1 operating expenses SEK -9.497 thousand
Recent news on Spago Nanomedical AB (publ)
See all newsBrief: Spago Nanomedical Announces Outcome Of Rights Issue
Brief: Spago Nanomedical Resolves On Rights Issue Of About SEK 16 Million
Sweden's Spago Nanomedical Q1 loss narrows
Brief: Spago Nanomedical Q1 Sales SEK 22 Thousand
Brief: Spago Nanomedical Says Tumorad-01 Study Meets Primary Endpoint Of Maximum Tolerated Dose